Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
We aimed to analyze the value of seizure reduction and radiological response as prognostic markers of survival in patients with low-grade glioma (LGG) treated with temozolomide (TMZ) chemotherapy. We retrospectively reviewed adult patients with a progressive LGG and uncontrolled epilepsy in two hosp...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer US
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718947/ |